Legend Biotechcorp Stock Return On Equity

LEGN Stock

USD 46.19 0.93 1.97%

Legend BiotechCorp fundamentals help investors to digest information that contributes to Legend BiotechCorp's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend BiotechCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend BiotechCorp stock.

		Last Reported	Projected for Next Year
	Return On Equity	(0.41)	(0.43)

As of the 20th of April 2024, Return On Equity is likely to drop to -0.43.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Legend BiotechCorp Company Return On Equity Analysis

Legend BiotechCorp's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Legend BiotechCorp Return On Equity

-0.52

Most of Legend BiotechCorp's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend BiotechCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Legend Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Legend BiotechCorp is extremely important. It helps to project a fair market value of Legend Stock properly, considering its historical fundamentals such as Return On Equity. Since Legend BiotechCorp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend BiotechCorp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend BiotechCorp's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Long Term Debt Total	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Short Term Investments	Net Invested Capital	Capital Stock	Net Working Capital	Short Term Debt	Good Will	Long Term Debt
Total Assets		0.88	0.91	-0.93	0.78	-0.55	0.78	0.89	1.0	0.66	0.98	0.93	-0.05	-0.89	0.59	0.89	0.98	0.89	0.9	0.72	0.85
Total Stockholder Equity	0.88		0.98	-0.98	0.69	-0.32	0.59	0.75	0.88	0.89	0.89	0.77	-0.13	-0.98	0.36	1.0	0.91	1.0	0.82	0.83	0.91
Net Tangible Assets	0.91	0.98		-0.98	0.76	-0.42	0.63	0.81	0.92	0.78	0.94	0.83	-0.2	-0.96	0.51	0.98	0.96	0.98	0.87	0.73	0.9
Retained Earnings	-0.93	-0.98	-0.98		-0.72	0.47	-0.71	-0.85	-0.93	-0.83	-0.95	-0.87	0.07	0.97	-0.49	-0.98	-0.96	-0.99	-0.86	-0.79	-0.89
Accounts Payable	0.78	0.69	0.76	-0.72		-0.63	0.63	0.7	0.77	0.42	0.77	0.74	-0.62	-0.58	0.68	0.72	0.76	0.67	0.94	0.44	0.88
Net Receivables	-0.55	-0.32	-0.42	0.47	-0.63		-0.89	-0.81	-0.53	-0.04	-0.57	-0.77	0.16	0.29	-0.81	-0.34	-0.56	-0.34	-0.61	-0.01	-0.34
Long Term Debt Total	0.78	0.59	0.63	-0.71	0.63	-0.89		0.93	0.75	0.41	0.76	0.92	0.09	-0.6	0.63	0.59	0.76	0.61	0.73	0.42	0.54
Total Liab	0.89	0.75	0.81	-0.85	0.7	-0.81	0.93		0.87	0.51	0.89	0.96	0.01	-0.76	0.74	0.76	0.89	0.78	0.77	0.49	0.66
Total Current Assets	1.0	0.88	0.92	-0.93	0.77	-0.53	0.75	0.87		0.65	0.99	0.92	-0.05	-0.89	0.59	0.89	0.98	0.89	0.89	0.72	0.84
Intangible Assets	0.66	0.89	0.78	-0.83	0.42	-0.04	0.41	0.51	0.65		0.64	0.53	0.09	-0.88	-0.05	0.87	0.67	0.88	0.59	0.95	0.78
Common Stock	0.98	0.89	0.94	-0.95	0.77	-0.57	0.76	0.89	0.99	0.64		0.95	-0.07	-0.9	0.65	0.9	1.0	0.9	0.9	0.66	0.83
Property Plant Equipment	0.93	0.77	0.83	-0.87	0.74	-0.77	0.92	0.96	0.92	0.53	0.95		0.02	-0.79	0.72	0.78	0.94	0.79	0.87	0.55	0.71
Current Deferred Revenue	-0.05	-0.13	-0.2	0.07	-0.62	0.16	0.09	0.01	-0.05	0.09	-0.07	0.02		-0.05	-0.33	-0.16	-0.07	-0.08	-0.38	0.16	-0.41
Net Debt	-0.89	-0.98	-0.96	0.97	-0.58	0.29	-0.6	-0.76	-0.89	-0.88	-0.9	-0.79	-0.05		-0.32	-0.97	-0.92	-0.99	-0.76	-0.84	-0.83
Short Term Investments	0.59	0.36	0.51	-0.49	0.68	-0.81	0.63	0.74	0.59	-0.05	0.65	0.72	-0.33	-0.32		0.39	0.63	0.38	0.61	-0.08	0.38
Net Invested Capital	0.89	1.0	0.98	-0.98	0.72	-0.34	0.59	0.76	0.89	0.87	0.9	0.78	-0.16	-0.97	0.39		0.92	1.0	0.84	0.82	0.93
Capital Stock	0.98	0.91	0.96	-0.96	0.76	-0.56	0.76	0.89	0.98	0.67	1.0	0.94	-0.07	-0.92	0.63	0.92		0.92	0.89	0.67	0.84
Net Working Capital	0.89	1.0	0.98	-0.99	0.67	-0.34	0.61	0.78	0.89	0.88	0.9	0.79	-0.08	-0.99	0.38	1.0	0.92		0.81	0.82	0.89
Short Term Debt	0.9	0.82	0.87	-0.86	0.94	-0.61	0.73	0.77	0.89	0.59	0.9	0.87	-0.38	-0.76	0.61	0.84	0.89	0.81		0.62	0.92
Good Will	0.72	0.83	0.73	-0.79	0.44	-0.01	0.42	0.49	0.72	0.95	0.66	0.55	0.16	-0.84	-0.08	0.82	0.67	0.82	0.62		0.78
Long Term Debt	0.85	0.91	0.9	-0.89	0.88	-0.34	0.54	0.66	0.84	0.78	0.83	0.71	-0.41	-0.83	0.38	0.93	0.84	0.89	0.92	0.78

Click cells to compare fundamentals

For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Competition

Predict Legend BiotechCorp

Return On Equity Over Time

Legend Total Stockholder Equity

Total Stockholder Equity

1.31 Billion

At this time, Legend BiotechCorp's Total Stockholder Equity is very stable compared to the past year.

Based on the latest financial disclosure, Legend BiotechCorp has a Return On Equity of -0.5194. This is 97.83% lower than that of the Biotechnology sector and 98.58% lower than that of the Health Care industry. The return on equity for all United States stocks is 67.55% higher than that of the company.

Legend Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend BiotechCorp's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend BiotechCorp could also be used in its relative valuation, which is a method of valuing Legend BiotechCorp by comparing valuation metrics of similar companies.

Legend BiotechCorp is currently under evaluation in return on equity category among related companies.

Legend Fundamentals

	Return On Equity	-0.52
	Return On Asset	-0.17
	Profit Margin	(1.82) %
	Operating Margin	(1.52) %
	Current Valuation	16.16 B
	Shares Outstanding	181.91 M
	Shares Owned By Insiders	1.30 %
	Shares Owned By Institutions	48.69 %
	Number Of Shares Shorted	9.99 M
	Price To Book	7.69 X
	Price To Sales	33.76 X
	Revenue	285.14 M
	Gross Profit	(284.01 M)
	EBITDA	(421.76 M)
	Net Income	(518.25 M)
	Cash And Equivalents	791.26 M
	Cash Per Share	5.11 X
	Total Debt	328.67 M
	Debt To Equity	0.29 %
	Current Ratio	3.83 X
	Book Value Per Share	6.88 X
	Cash Flow From Operations	(384.47 M)
	Short Ratio	9.56 X
	Earnings Per Share	(2.94) X
	Target Price	86.16
	Number Of Employees	1.8 K
	Beta	0.014
	Market Capitalization	8.57 B
	Total Asset	1.85 B
	Retained Earnings	(1.48 B)
	Working Capital	1.28 B
	Net Asset	1.85 B

About Legend BiotechCorp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Legend BiotechCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend BiotechCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend BiotechCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Legend BiotechCorp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend BiotechCorp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotechcorp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotechcorp Stock:

How To Invest In Legend

Details

Is Legend Stock a good investment?

Details

What is Legend BiotechCorp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis.

To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.

	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Share Portfolio Track or share privately all of your investments from the convenience of any device

Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.94)

Revenue Per Share

1.619

Quarterly Revenue Growth

1.876

Return On Assets

(0.17)

Return On Equity

(0.52)

The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Legend Biotechcorp Stock Return On Equity

Legend BiotechCorp Company Return On Equity Analysis

Return On Equity

Net Income

Total Equity

Current Legend BiotechCorp Return On Equity

Legend Return On Equity Driver Correlations

Legend Total Stockholder Equity

Total Stockholder Equity

1.31 Billion

Legend Return On Equity Peer Comparison

Legend Fundamentals

About Legend BiotechCorp Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Legend Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY